NVision
Quantum MRI and computing for healthcare
About
Founded circa 2020, NVision develops advanced quantum sensing and quantum computing technologies primarily targeting healthcare applications including quantum MRI systems and drug development platforms. Originating in Ulm, Germany, the company raised a $30M Series A to commercialize quantum physics-based MRI devices and secured a $55M Series B to expand into quantum computing for healthcare innovation and drug discovery. NVision's business model focuses on delivering cutting-edge hardware and software quantum solutions for life sciences institutions and pharmaceutical companies seeking improved imaging and computational capabilities.
Products
- Quantum MRI Systems
- Quantum Computing Platform for Healthcare
Market research & competitive positioning
Source-backed TAM / SAM / SOM sizing, displacement analysis, and an interactive peer positioning map for NVision — available to members.
